Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
13.55
+0.10 (0.74%)
Mar 9, 2026, 1:21 PM EDT - Market open
TNXP Employees
Tonix Pharmaceuticals Holding had 81 employees as of December 31, 2024. The number of employees decreased by 22 or -21.36% compared to the previous year.
Employees
81
Change (1Y)
-22
Growth (1Y)
-21.36%
Revenue / Employee
$127,148
Profits / Employee
-$1,224,926
Market Cap
173.36M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Caribou Biosciences | 147 |
| Heron Therapeutics | 128 |
| Vaxart | 105 |
| Nkarta | 105 |
| Cartesian Therapeutics | 66 |
| SAB Biotherapeutics | 63 |
| Whitehawk Therapeutics | 22 |
| Sagimet Biosciences | 14 |
TNXP News
- 3 days ago - Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development - GlobeNewsWire
- 5 days ago - Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2026 American Academy of Pain Medicine PainConnect Annual Meeting - GlobeNewsWire
- 6 days ago - Tonix Pharmaceuticals Stock Dips After Nasdaq Uplisting - Benzinga
- 6 days ago - Tonix Pharmaceuticals Announces Uplisting from Nasdaq Capital Market to Nasdaq Global Select Market - GlobeNewsWire
- 12 days ago - Tonix Pharmaceuticals to Participate in Two Investor Conferences in March - GlobeNewsWire
- 5 weeks ago - Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit - GlobeNewsWire
- 2 months ago - Tonix Pharmaceuticals to Present at Two Investor Conferences in January 2026 - GlobeNewsWire
- 2 months ago - Tonix Pharmaceuticals Announces Pricing of $20.0 Million Registered Direct Offering - GlobeNewsWire